95 related articles for article (PubMed ID: 8655632)
21. CGP 41251 and tamoxifen selectively inhibit mitogen-activated protein kinase activation and c-Fos phosphoprotein induction by substance P in human astrocytoma cells.
Luo W; Sharif TR; Houghton PJ; Sharif M
Cell Growth Differ; 1997 Nov; 8(11):1225-40. PubMed ID: 9372245
[TBL] [Abstract][Full Text] [Related]
22. Ability of okadaic acid and other protein phosphatase inhibitors to mimic the stimulatory effects of 12-O-tetradecanoylphorbol-13-acetate on hydroperoxide production in mouse epidermis in vivo.
Newell SW; Perchellet EM; Gao XM; Chen G; Perchellet JP
Cancer Lett; 1996 Jan; 98(2):241-51. PubMed ID: 8556715
[TBL] [Abstract][Full Text] [Related]
23. Activation of stress-activator protein kinase/c-Jun N-terminal kinase by the non-TPA-type tumor promoter palytoxin.
Kuroki DW; Bignami GS; Wattenberg EV
Cancer Res; 1996 Feb; 56(3):637-44. PubMed ID: 8564984
[TBL] [Abstract][Full Text] [Related]
24. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
25. H-7, a protein kinase C inhibitor, inhibits phorbol ester-caused ornithine decarboxylase induction but fails to inhibit phorbol ester-caused suppression of epidermal growth factor binding in primary cultured mouse epidermal cells.
Nakadate T; Yamamoto S; Aizu E; Nishikawa K; Kato R
Mol Pharmacol; 1989 Dec; 36(6):917-24. PubMed ID: 2601687
[TBL] [Abstract][Full Text] [Related]
26. Contrasting effects of two tumour promoters, phorbol myristate acetate and okadaic acid, on T-cell responses and activation of p42 MAP-kinase/ERK-2.
Amaral MC; Casillas AM; Nel AE
Immunology; 1993 May; 79(1):24-31. PubMed ID: 8389730
[TBL] [Abstract][Full Text] [Related]
27. Retinoic acid and phorbol ester synergistically up-regulate IL-8 expression and specifically modulate protein kinase C-epsilon in human skin fibroblasts.
Zhang QY; Hammerberg C; Baldassare JJ; Henderson PA; Burns D; Ceska M; Voorhees JJ; Fisher GJ
J Immunol; 1992 Aug; 149(4):1402-8. PubMed ID: 1323613
[TBL] [Abstract][Full Text] [Related]
28. Phorbol ester-dependent regulation of nuclear protein tyrosine phosphatase in situ.
Heimerl P; Stader C; Willmann R; Hofer HW
Cell Signal; 1995 May; 7(4):341-50. PubMed ID: 8527303
[TBL] [Abstract][Full Text] [Related]
29. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site.
Saksela K; Mäkelä TP; Hughes K; Woodgett JR; Alitalo K
Oncogene; 1992 Feb; 7(2):347-53. PubMed ID: 1312697
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of jun family gene expression by the tumor promoter okadaic acid.
Schönthal A; Alberts AS; Frost JA; Feramisco JR
New Biol; 1991 Oct; 3(10):977-86. PubMed ID: 1662987
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological targeting of signaling pathways in protein kinase C-stimulated superoxide generation in neutrophil-like HL-60 cells: effect of phorbol ester, arachidonic acid and inhibitors of kinase(s), phosphatase(s) and phospholipase A2.
Mayer AM; Brenic S; Glaser KB
J Pharmacol Exp Ther; 1996 Nov; 279(2):633-44. PubMed ID: 8930166
[TBL] [Abstract][Full Text] [Related]
32. Regulation of mammalian ribonucleotide reductase by the tumor promoters and protein phosphatase inhibitors okadaic acid and calyculin A.
Hurta RA; Wright JA
Biochem Cell Biol; 1992; 70(10-11):1081-7. PubMed ID: 1338411
[TBL] [Abstract][Full Text] [Related]
33. Activation of epidermal akt by diverse mouse skin tumor promoters.
Lu J; Rho O; Wilker E; Beltran L; Digiovanni J
Mol Cancer Res; 2007 Dec; 5(12):1342-52. PubMed ID: 18171992
[TBL] [Abstract][Full Text] [Related]
34. Exposure of normal human melanocytes to a tumor promoting phorbol ester reverses growth suppression by transforming growth factor beta.
Stavroulaki M; Kardassis D; Chatzaki E; Sakellaris G; Lindschau C; Haller H; Tosca A; Krasagakis K
J Cell Physiol; 2008 Feb; 214(2):363-70. PubMed ID: 17654516
[TBL] [Abstract][Full Text] [Related]
35. Regulation of c-jun expression during induction of monocytic differentiation by okadaic acid.
Kharbanda S; Datta R; Rubin E; Nakamura T; Hass R; Kufe D
Cell Growth Differ; 1992 Jul; 3(7):391-9. PubMed ID: 1419903
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of Na-K-Cl cotransport by protein kinase C is mediated by protein phosphatase 1 in pigmented ciliary epithelial cells.
Layne J; Yip S; Crook RB
Exp Eye Res; 2001 Apr; 72(4):371-9. PubMed ID: 11273665
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase.
Tamir A; Granot Y; Isakov N
J Immunol; 1996 Aug; 157(4):1514-22. PubMed ID: 8759733
[TBL] [Abstract][Full Text] [Related]
38. The non-phorbol ester tumor promoter okadaic acid does not promote morphological transformation or inhibit junctional communication in hamster embryo cells.
Rivedal E; Mikalsen SO; Sanner T
Biochem Biophys Res Commun; 1990 Mar; 167(3):1302-8. PubMed ID: 2322276
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of action of okadaic acid class tumor promoters on mouse skin.
Fujiki H; Suganuma M; Yoshizawa S; Nishiwaki S; Winyar B; Sugimura T
Environ Health Perspect; 1991 Jun; 93():211-4. PubMed ID: 1663450
[TBL] [Abstract][Full Text] [Related]
40. Dysfunction of protein kinase FA/GSK-3 alpha in lymphocytes of patients with schizophrenic disorder.
Yang SD; Yu JS; Lee TT; Yang CC; Ni MH; Yang YY
J Cell Biochem; 1995 Sep; 59(1):108-16. PubMed ID: 8530529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
